|
HS Code |
990255 |
| Common Name | 6-Amino-5-nitronicotinic acid |
| Iupac Name | 6-amino-5-nitropyridine-3-carboxylic acid |
| Molecular Formula | C6H5N3O4 |
| Molecular Weight | 183.12 g/mol |
| Cas Number | 5350-94-3 |
| Appearance | Yellow crystalline solid |
| Melting Point | 276-278°C |
| Solubility In Water | Slightly soluble |
| Smiles | C1=CC(=NC=C1C(=O)O)[N+](=O)[N-]N |
| Inchi | InChI=1S/C6H5N3O4/c7-6-5(9(12)13)2-1-4(3-8)10-6/h1-3H,(H,10,11)(H2,7,8) |
As an accredited 3-pyridinecarboxylic acid, 6-amino-5-nitro- factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a 25g amber glass bottle with a screw cap, labeled "6-Amino-5-nitro-3-pyridinecarboxylic acid, for laboratory use." |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for 3-pyridinecarboxylic acid, 6-amino-5-nitro-: Safely packed, moisture-proof, 16–18 MT net, in 25kg bags/drums. |
| Shipping | 3-Pyridinecarboxylic acid, 6-amino-5-nitro- should be shipped in a tightly sealed container, protected from light, moisture, and incompatible substances. Transport according to relevant chemical safety regulations, using proper labeling and documentation. Ensure secondary containment and temperature control if required, and handle with appropriate personal protective equipment (PPE) during packaging and shipping. |
| Storage | **Storage Description for 3-Pyridinecarboxylic Acid, 6-Amino-5-Nitro-:** Store in a tightly sealed container in a cool, dry, and well-ventilated area, away from sources of heat, ignition, and incompatible substances such as strong oxidizers or bases. Protect from moisture and direct sunlight. Proper labeling and secure storage are essential to prevent accidental exposure or contamination. Handle with appropriate personal protective equipment. |
| Shelf Life | The shelf life of 3-pyridinecarboxylic acid, 6-amino-5-nitro- is typically 2–3 years when stored in a cool, dry place. |
|
Purity 98%: 3-pyridinecarboxylic acid, 6-amino-5-nitro- with purity 98% is used in pharmaceutical intermediate synthesis, where high purity ensures reduced side-product formation. Melting Point 252°C: 3-pyridinecarboxylic acid, 6-amino-5-nitro- with melting point 252°C is used in high-temperature organic reactions, where thermal stability enables process reliability. Molecular Weight 197.13 g/mol: 3-pyridinecarboxylic acid, 6-amino-5-nitro- with molecular weight 197.13 g/mol is used for heterocyclic compound formulation, where accurate molecular weight ensures target compound integrity. Particle Size <20 microns: 3-pyridinecarboxylic acid, 6-amino-5-nitro- with particle size <20 microns is used in catalytic material production, where fine particle size enhances reaction surface area. Water Solubility 15 mg/L: 3-pyridinecarboxylic acid, 6-amino-5-nitro- with water solubility 15 mg/L is used in aqueous-phase reaction systems, where controlled solubility aids in gradual reactant diffusion. Stability Temperature up to 120°C: 3-pyridinecarboxylic acid, 6-amino-5-nitro- with stability temperature up to 120°C is used in chemical processing pipelines, where high stability prevents decomposition during operation. Assay by HPLC ≥99%: 3-pyridinecarboxylic acid, 6-amino-5-nitro- with assay by HPLC ≥99% is used in active pharmaceutical ingredient manufacturing, where precise assay yields consistent batch quality. |
Competitive 3-pyridinecarboxylic acid, 6-amino-5-nitro- prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
On the shop floor, the sequence always begins with the right raw materials and vigilance over every reaction step. Our chemists and operators keep an eye on color, purity, and changes in odor, using years of experience to interpret the signals that precede successful synthesis. We’ve seen every batch of 3-pyridinecarboxylic acid, 6-amino-5-nitro- come off the line, checked the nuances between successful and subpar runs, and learned what real control over nitration and amination can bring to specialty intermediates.
Unlike generic pyridinecarboxylic acids that end up as run-of-the-mill ligands or simple pharmaceutical building blocks, 3-pyridinecarboxylic acid, 6-amino-5-nitro- holds a more challenging chemistry. That nitro group at the 5-position complicates synthesis. It hits solubility and reactivity differently, shifting the product’s destiny away from the everyday. The addition of the amino group at the 6-position opens routes for both reductive and coupling reactions that are impossible with unsubstituted pyridines, giving downstream chemists new levers for molecular tuning.
On the production floor, the difference always emerges in the details. We grind raw input from trusted suppliers, push the reaction under tightly monitored temperature and time, and use private, field-tested purification techniques rather than open commoditized ones. At the end, assays using HPLC and spectroscopy judge every kilogram. Typical batches fall within the 98.5%–99.5% purity range. Moisture content stays below 0.5%. Appearance—usually a yellow powder—confirms correct process control, but technicians skip nothing and run further checks to spot any abnormal particles or shades.
One thing rarely mentioned in sales sheets: odor gives away a poorly controlled run right away. A sharp or burnt aroma signals byproduct carryover, whether residual solvent or failed protection. Our QC specialists, who have worked here for over a decade, can recognize it in seconds. This kind of practical detail defines what separates production at scale from theoretical synthetic routes in journals or demo runs in a university lab.
Most of our batches head toward pharmaceutical and agrochemical synthesis. Researchers appreciate the ready access of both nitro and amino groups. The nitro handle enables further functionalization using reduction or substitution methods, while the amino can be protected, acetylated, or directly coupled. Medicinal chemists reach for this intermediate when designing heterocyclic compounds for anti-infective or anti-inflammatory action. We’ve worked with research teams who found that subtle changes in substitution pattern can increase target specificity—a real puzzle that requires inputs with unambiguous structure and minimal contaminants.
Some partners, working on crop protection, use the molecule’s reactivity for creating bioactive heterocycles. The amino group gives them a route to link with acid chlorides, while the nitro transforms under catalytic hydrogenation. In both cases, they need tight consistency across batches. Anything out of specification means hours lost on compound purification further down the line, which can delay regulatory registration or patent filings.
Anyone who has scaled up pyridine derivatives knows the complications that arise from moving beyond para or meta substitutions. Adding functional groups like nitro and amino to the same ring involves reaction steps prone to side-product formation and overreaction. In 3-pyridinecarboxylic acid, 6-amino-5-nitro-, these challenges are not just theoretical—they appear at every step, from exotherm management to work-up yields and isolation. Generic 3-pyridinecarboxylic acid lacks this complexity and so comes with fewer headaches in production, but it fails to deliver versatility for specialized syntheses.
Other products in the pyridinecarboxylic category may lean toward dye intermediates or simple chelation chemistry. Introducing both electron-donating (amino) and electron-withdrawing (nitro) groups in precise locations disrupts standard behavior. Recrystallization, for example, can’t always be done with basic solvent systems. Unrefined product or those coming from less-experienced teams usually clog filtration beds and make downstream dissolution uneven. Over the years, our chemical engineers have fine-tuned procedures step by step, minimizing “gummy” residues and batch-to-batch drift. This end-to-end reliability matters for scale-up chemists; regrets from skipping those incremental improvements usually show up in process down-times or failed analytical releases.
Decades of serving international development teams taught us how regulatory climates keep shifting. As a manufacturer, we adapt standard operation to comply with evolving documentation, traceability, and impurity control requirements. Our products serve teams facing demanding audits, not just casual research setups. From stability documentation to full lot traceability, our plant team records every step—date, operator, solvent batch, condition logs—so the final COA covers the whole journey.
Production for the nitro and amino chemistry category draws attention from environmental authorities due to byproduct risks. Nitration steps carry both explosion hazard and post-process washout demands. We cut nitrous emissions at the source, recuperate and neutralize spent acids, and keep thorough logs for downstream wastewater streams. We have our own treatment lab in the plant, run by engineers who’ve taken our waste profile from compliance headaches in the 1990s to a solid safety record today. Researchers visiting our plant sometimes ask to walk the treatment line; they know their own company’s social and environmental commitments depend on partners who deliver genuine care in upstream practices.
After long years making 3-pyridinecarboxylic acid, 6-amino-5-nitro-, we learned that formal documentation alone doesn’t build trust. Having a quality system and living it are separate realities. Training cycles never stop. We run mock recalls, interrogate every deviation, and challenge batch results with third-party checks at random. Staff meetings tackle recurring process hiccups. A slow filtration or a trace impurity left to recur can cascade into thousands of euros in lost time for a customer. We’ve walked visits with procurement officers who ask about single impurity spots on chromatograms—exactly the kind of transparency real manufacturing partners value, and what no generic product or trader can mimic.
Through direct exchanges, procurement and R&D leads rarely just want “specs.” Their first questions usually go to questions of supply stability, impurity profiles, analytical signatures, and bulk packaging history. They want to know how we reacted to a power outage or raw material shortage. Our teams don’t offer simple reassurances—we show decade-old logs with performance curves, impurity tracking sheets, and photos of packaging lines. Old clients recall solvent shortages or logistics delays, and appreciate how we run buffer stocks and schedule redundancy. Over time, that trust builds not on marketing but by years of consistent, visible practice. We’ve learned that reputation with informed buyers stands or falls on these unvarnished details.
Lab chemistry for 3-pyridinecarboxylic acid, 6-amino-5-nitro- reads elegantly in published articles, but industrial production is another world. Small changes—ambient humidity, water content in solvents, milling fineness of starting pyridine—quickly translate into process variability. Feeding the reactor too quickly can spike temperature; too slowly, and yields plummet. We document, then test, then revise. Equipment upgrades and swap-outs come at a price, but skipping them leads inevitably to downstream headaches. Our plant made a leap in batch reproducibility after moving from open kettle work-ups to closed, jacketed systems fitted with automated pH adjustment. Interlocking safety and monitoring cut hazardous venting, which flagged environmental audits in the past.
R&D teams visiting us for custom intermediates sometimes want process changes on the fly. Years in production taught us that any shortcut or step change involves risk. We walk through every proposed tweak, simulate in pilot reactors, and carry changes over only after multiple successful trials. Skipping steps or ignoring learnings from previous batches costs everyone more in the long run. Sometimes being blunt saves wasted cycles and the resulting extra labor, unexpected delays, and lost client trust.
HPLC, GC-MS, and NMR checks fill our routine logs. High purity matters, but so does knowing likely side products—both for regulatory filings and for those creating high-value derivatives. Over the decades, our analytical chemists built a database of potential trace contaminants. This doesn’t exist in a datasheet. It emerges from real samples, knows what a positive spot for each synthesis route looks like, and flags deviations before they creep into user labs. Clients working on patent filings benefit—they avoid litigation over unknown or undeclared residues by having documentation and spectra reaching back years, not just batch by batch. For those in drug development and regulated crop protection, this transparency streamlines submission and supports risk assessments.
Decades in chemical manufacturing taught us that shipping stability outlasts any temporary market. Disruptions in raw material flow, pressure on export approvals, sudden regulatory shifts—none are hypothetical for anyone making specialty chemistries today. We maintain regular risk reviews and dual-code supplier relationships. Few buyers notice fine points like custom drum linings that prevent caking in transit, but after having to rescue a multimillion-euro batch ruined by condensation in transit years ago, we never returned to commoditized packaging. Throughout border slowdowns, our logistics team pivots to warehousing, alternate ports, and chartered trucking when needed. Long-term clients continue buying not just for the product, but for proof that delivery under stress remains reliable.
Hormone regulation agents, antimicrobial development, next-generation crop protectants—all lean into structurally clever compounds. Experience shows that turning synthetic ideas into industrially relevant outputs takes more than access to a raw chemical. It takes long-term consistency, deep competency with regulatory realities, and a willingness to adapt fully to the shifting endpoints of innovative research.
As a producer with years of firsthand knowledge, we focus on delivering not just the molecule, but also the reliability and transparency researchers and manufacturers worldwide rely on. Each batch contains embedded experience across thousands of cycles—the tweaks, vigilance, risk management, and honest reporting that real users recognize and count on. That’s not something that can be traded or resold. It shows up in the results, in the trust our clients build with their own regulators and auditors, and in the new molecules that shape tomorrow’s innovations.